OPEN END TURBO LONG - POLE GROU | Real-time Bid/Ask 07:42:24 2024-06-06 EDT | ||
| 1.36 EUR / 1.4 EUR | +12.20% |
|
| Current month | +4.24% | ||
| 1 month | +18.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 1.38 | +12.20% |
| 24-06-05 | 1.23 | -5.38% |
| 24-06-04 | 1.3 | +7.44% |
| 24-06-03 | 1.21 | +2.54% |
| 24-05-31 | 1.18 | -4.84% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 03:58 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Morgan Stanley |
| WKN | MG0HZ5 |
| ISIN | DE000MG0HZ58 |
| Date issued | 2024-03-20 |
| Strike | 20.28 CHF |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.47 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.4 € |
|---|---|
| Lowest since issue | 0.51 € |
| Spread | 0.04 € |
| Spread % | 2.86% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
33.55
EUR
Average target price
25.12
EUR
Spread / Average Target
-25.11%
- Stock Market
- Certificates
- Certificat
